Journal of Pathology Clinical Research

Papers
(The median citation count of Journal of Pathology Clinical Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
SWI/SNF‐deficiency defines highly aggressive undifferentiated endometrial carcinoma40
Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease29
DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’28
Higher prevalence of pulmonary macrothrombi in SARS‐CoV‐2 than in influenza A: autopsy results from ‘Spanish flu’ 1918/1919 in Switzerland to Coronavirus disease 201927
Characterisation of cardiac pathology in 23 autopsies of lethal COVID‐1926
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore26
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases26
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation26
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma25
Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid23
Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer22
Spatial analysis of tumor‐infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma22
Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations21
Variability in grading of ductal carcinoma in situ among an international group of pathologists21
The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients21
Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features20
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer20
Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population19
The ethical challenges of artificial intelligence‐driven digital pathology19
Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis17
Explainability and causability in digital pathology16
Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer15
Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma14
Quick Annotator: an open‐source digital pathology based rapid image annotation tool14
TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms14
Dysbalance of ACE2 levels – a possible cause for severe COVID‐19 outcome in COPD14
Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types14
An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification14
More than just acral melanoma: the controversies of defining the disease13
KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway13
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors12
Intra‐ and extra‐cranial BCOR‐ITD tumours are separate entities within the BCOR‐rearranged family12
The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer12
Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation12
Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma11
MYC amplifications are common events in childhood osteosarcoma11
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors11
Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer11
Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas11
PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules11
pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical p11
Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma11
The presence of tumour‐infiltrating neutrophils is an independent adverse prognostic feature in clear cell renal cell carcinoma11
Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy10
Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants10
CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma10
Colonic epithelial cathelicidin (LL‐37) expression intensity is associated with progression of colorectal cancer and presence of CD8+ T cell infiltrate9
KRAS mutations and endometriosis burden of disease9
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer9
Reliable computational quantification of liver fibrosis is compromised by inherent staining variation9
A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma progression and resistance to chemoradiotherapy in locally advanced rectal ca9
Malignant transformation of salivary gland pleomorphic adenoma: proof of principle9
Understanding the ethical and legal considerations of Digital Pathology9
A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer9
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study8
Optimization of deep learning models for the prediction of gene mutations using unsupervised clustering8
Characterizing the tumor microenvironment in rare renal cancer histological types8
STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?8
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy8
A series of COVID‐19 autopsies with clinical and pathologic comparisons to both seasonal and pandemic influenza8
Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer8
Clinicopathological characteristics of Epstein–Barr virus and microsatellite instability subtypes of early gastric neoplasms classified by the Japanese and the World Health Organization cri7
Deep learning‐based image analysis reveals significant differences in the number and distribution of mucosal CD3 and γδ T cells between Crohn's disease and ulcerative colitis7
Overactivation of the IGF signalling pathway in osteosarcoma: a potential therapeutic target?7
Post‐operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression6
Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation6
Digital image analysis in pathologist‐selected regions of interest predicts survival more accurately than whole‐slide analysis: a direct comparison study in 153 gastric carcinomas6
PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways6
Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell car6
Predicting microsatellite instability and key biomarkers in colorectal cancer from H&E‐stained images: achieving state‐of‐the‐art predictive performance with fewer data using Swin Transformer5
Whole‐exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma5
PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer5
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours5
c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma5
The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies5
Automated annotations of epithelial cells and stroma in hematoxylin–eosin‐stained whole‐slide images using cytokeratin re‐staining5
PRAME protein expression in DICER1‐related tumours5
Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity4
Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric aden4
High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma4
CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer4
Pathologic T1 and T2 encapsulated invasive carcinomas arising from mucinous cystic neoplasms of the pancreas have favorable prognosis and might be treated conservatively4
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation4
CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways4
Engineering the future of 3D pathology4
Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study4
Chromosome 2q gain and epigenetic silencing of GATA3 in microglandular adenosis of the breast4
Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups4
Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry3
Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma3
A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome3
Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?3
Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin–angiotensin system inhibitors on its prognosis3
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma3
Exosome‐derived ANXA9 functions as an oncogene in breast cancer3
Identifying primary tumor site of origin for liver metastases via a combination of handcrafted and deep learning features3
CD70 and PD‐L1 (CD274) co‐expression predicts poor clinical outcomes in patients with pleural mesothelioma3
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial3
PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients3
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations3
Development of multiple AI pipelines that predict neoadjuvant chemotherapy response of breast cancer using H&E‐stained tissues3
Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma3
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis3
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention2
Increased diagnostic sensitivity of palpation‐guided thyroid nodule fine‐needle aspiration cytology by BRAF V600E‐mutation analysis2
AI‐based intra‐tumor heterogeneity score of Ki67 expression as a prognostic marker for early‐stage ER+/HER2− breast cancer2
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers2
NTRK gene aberrations in triple‐negative breast cancer: detection challenges using IHC, FISH, RT‐PCR, and NGS2
2
Identification of a prognostic signature in colorectal cancer using combinatorial algorithm‐driven analysis2
Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer2
Application of direct stochastic optical reconstruction microscopy (dSTORM) to the histological analysis of human glomerular disease2
Digital image analysis allows objective stratification of patients with silent PIT1‐lineage pituitary neuroendocrine tumors2
Real‐life data from standardized preanalytical coding (SPREC) in tissue biobanking and its dual use for sample characterization and process optimization2
CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer2
2
High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer2
Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas2
0.026112079620361